208 related articles for article (PubMed ID: 2567980)
1. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
Kumar R; Dunn LL
Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
[TBL] [Abstract][Full Text] [Related]
2. Oncogene detection at the single cell level.
Kumar R; Barbacid M
Oncogene; 1988 Dec; 3(6):647-51. PubMed ID: 2578002
[TBL] [Abstract][Full Text] [Related]
3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
4. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.
Kahn SM; Jiang W; Culbertson TA; Weinstein IB; Williams GM; Tomita N; Ronai Z
Oncogene; 1991 Jun; 6(6):1079-83. PubMed ID: 1676837
[TBL] [Abstract][Full Text] [Related]
5. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
8. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
10. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
Collins SJ
Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
[TBL] [Abstract][Full Text] [Related]
11. Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
Paranavitana CM
Mol Cell Probes; 1998 Oct; 12(5):309-15. PubMed ID: 9778456
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
[TBL] [Abstract][Full Text] [Related]
13. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
14. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
15. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
17. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
Stratton MR; Fisher C; Gusterson BA; Cooper CS
Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
[TBL] [Abstract][Full Text] [Related]
18. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
20. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
